The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial

Rosiglitazone is not associated with an increased risk of bladder cancer

(2013) Chin-Hsiao Tseng   Cancer Epidemiology

Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

(2013) John P. Bilezikian et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy

(2012) Allison C. Ross et al.   HIV CLINICAL TRIALS

Type 2 diabetes and bone

(2012) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone, sweet bone—osteoporotic fractures in diabetes mellitus

(2012) Christine Hamann et al.   Nature Reviews Endocrinology

Pioglitazone and the risk of bladder cancer

(2012) D. Hillaire-Buys et al.   BMJ-British Medical Journal

A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d

(2011) J. L. C. Borges et al.   DIABETES OBESITY & METABOLISM

Rosiglitazone Revisited

(2010) Steven E. Nissen et al.   ARCHIVES OF INTERNAL MEDICINE

ORIGINAL ARTICLE: Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study

(2010) Zehra Berberoglu et al.   CLINICAL ENDOCRINOLOGY

Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003-2009

(2010) A. Cohen et al.   DIABETES CARE

A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes

(2009) Daniel H. Solomon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes

(2009) Bernard Zinman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study

(2009) Ian J. Douglas et al.   PLOS MEDICINE

Use of Thiazolidinediones and Fracture Risk

(2008) Christian Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

(2008) Y. K. Loke et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)

(2008) S. E. Kahn et al.   DIABETES CARE

Thiazolidinedione-induced skeletal fragility - mechanisms and implications

(2008) Andrew Grey   DIABETES OBESITY & METABOLISM

Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial

(2008) Dorte Glintborg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Bone Structural Basis for Fracture Risk in Diabetes

(2008) L. Joseph Melton et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM